Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 47 for your search:
Cancer Type/Condition:  Pheochromocytoma
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PRESCRIPT2010.369, 2010:022417-25, NCT01379898

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793

3.

Phase: Phase III
Type: Diagnostic
Status: Approved-not yet active
Age: Not specified
Sponsor: Other
Protocol IDs: H10-02695, NCT01373736

4.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: IJBMNCASTOR, 2012-005545-20, NCT01860742

5.

Phase: Phase II, Phase I
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 93-102, NCT00579163

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130046, 13-C-0046, NCT01766635

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 1
Sponsor: NCI, Other
Protocol IDs: 04-148, MSKCC-04148, NCT00107289

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001CDE16, NCT00688623

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SNIPP, NCT00843037

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: MAW002, NCT00978211

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H-0710-049-223, NCT01152827

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: EudraCT 2006-004748-22, NCT01203306

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 78,256, NCT01237457

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IGR2010/1715, 2010-024621-20, MSI/A110356-31, NCT01371201

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: I206, NCT01396408

16.

Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130193, 13-C-0193, NCT01967537

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 140001, 14-C-0001, NCT01967576

18.

Phase: Phase II
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: UCSF-DOTA-TOC, NCT02177773

19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 2 to 25
Sponsor: NCI, Other
Protocol IDs: CDR0000257582, UIHC-200008086, NCI-V02-1710, 200008086, NCT00049023

20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: UCL/12/0499, NCT01941849

21.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2014-012-00CH1, NCT02267967

22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: Not specified
Sponsor: NICHD
Protocol IDs: 000093, 00-CH-0093, NCT00004847

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 3 to 70
Sponsor: NICHD
Protocol IDs: 000160, 00-CH-0160, NCT00005927

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Genetics, Screening
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: PHRC 04-01, NCT00188019

25.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Wue-Adrenal-Tumors-92/2002, NCT00669266
1   
New Search